Effect of Probiotics on Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
It has been reported that gut probiotics play a major role in the bidirectional communication between the gut and the brain. Probiotics may be essential to people with depression, which remains a global health challenge, as depression is a metabolic brain disorder. However, the efficacy of probiotics for depression is controversial. This study aimed to systematically review the existing evidence on the effect of probiotics-based interventions on depression. Randomized, controlled trials, identified through screening multiple databases and grey literature, were included in the meta-analysis. The meta-analysis was performed using Review Manager 5.3 software using a fixed-effects model. The meta-analysis showed that probiotics significantly decreased the depression scale score (MD (depressive disorder) = −0.30, 95% CI (−0.51–−0.09), p = 0.005) in the subjects. Probiotics had an effect on both the healthy population (MD = −0.25, 95% CI (−0.47–−0.03), p = 0.03) and patients with major depressive disorder (MDD) (MD = −0.73, 95% CI (−1.37–−0.09), p = 0.03). Probiotics had an effect on the population aged under 60 (MD = −0.43, 95% CI (−0.72–−0.13), p = 0.005), while it had no effect on people aged over 65 (MD = −0.18, 95% CI (−0.47–0.11), p = 0.22). This is the first systematic review and meta-analysis with the goal of determining the effect of probiotics on depression. We found that probiotics were associated with a significant reduction in depression, underscoring the need for additional research on this potential preventive strategy for depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent data on the psychological benefits of optimizing gut microbiota using probiotics, notably in reducing anxiety and depressive symptoms [108,109]”
From Are the gut bacteria telling us to eat or not to eat? reviewing the role of gut microbiota in the etiology, disease progression and treatment of eating disorders (2017) · cites this paper as [109]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Studies performed in healthy volunteers have shown that the administration of different probiotics were associated with an improved well-being (172–174)”
From Vagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders (2018) · cites this paper as [172]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Mohammadi, A. A., Jazayeri, S., Khosravi-Darani, K., Solati, Z., Mohammadpour, N., Asemi, Z., Adab, Z., Djalali, M., Tehrani-Doost, M., Hosseini, M., et al. (2016) · Nutritional Neuroscience · doi:10.1179/1476830515y.0000000023 · Cited by 239
RetractedKessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391 · cited 1×
“Nearly 20% of the population, at some point in their lifetime, will suffer depression [4].”
BackgroundBravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888
Altered fecal microbiota composition in patients with major depressive disorder
Jiang, H., Ling, Z., Zhang, Y., Mao, H., Ma, Z., Yin, Y., Wang, W., Tang, W., Tan, Z., Shi, J., et al. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.03.016 · Cited by 2,275 · cited 1×
“[18] analyzed fecal samples from 46 patients with depression and 30 healthy controls and found increased fecal bacteria in the depressed versus the healthy control group.”
BackgroundMessaoudi, M., Lalonde, R., Violle, N., Javelot, H., Desor, D., Nejdi, A., Bisson, J.-F., Rougeot, C., Pichelin, M., Cazaubiel, M., et al. (2011) · British Journal of Nutrition · doi:10.1017/s0007114510004319 · Cited by 1,324 · cited 8×
“In a double-blind placebo-controlled and randomized parallel group study by Messaoudi et al. [24], healthy volunteers took Lactobacillus helveticus R0052 and Bifidobacterium longum or a placebo for 30 days; the results showed decreased psychological stress, including depression, in subjects who took the probiotics reg…”
BackgroundMethodInfluentialCorrelation between the human fecal microbiota and depression
Naseribafrouei, A., Hestad, K., Avershina, E., Sekelja, M., Linløkken, A., Wilson, R., & Rudi, K. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12378 · Cited by 1,044 · cited 1×
“[17] analyzed fecal samples from 55 individuals (37 patients and 18 non-depressed controls) and found potential correlations between human fecal microbiota (as a proxy for gut microbiota) and depression.”
BackgroundEffects of the probiotic Bifidobacterium infantis in the maternal separation model of depression
Desbonnet, L., Garrett, L., Clarke, G., Kiely, B., Cryan, J. F., & Dinan, T. G. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.08.005 · Cited by 999 · cited 3×
“Experimentally elevated hypothalamic-pituitary-adrenal (HPA) axis responses and depression can be reversed in rats by administering a single bacterium, Bifidobacterium infantis [19].”
BackgroundResultInfluentialVilagut, G., Forero, C. G., Barbaglia, G., & Alonso, J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0155431 · Cited by 982 · cited 1×
“Depression is a common mental disorder, which can be long-lasting or recurrent, substantially impairing an individual’s ability to function in their daily life [1].”
Desbonnet, L., Garrett, L., Clarke, G., Bienenstock, J., & Dinan, T. G. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.03.009 · Cited by 952 · cited 1×
“Animal results show that the use of probiotics may lead to an increase in plasma tryptophan levels and reduced concentrations of serotonin in the frontal cortex and of cortical dopamine metabolites, thereby ameliorating depressive symptoms [20].”
BackgroundAkkasheh, G., Kashani-Poor, Z., Tajabadi-Ebrahimi, M., Jafari, P., Akbari, H., Taghizadeh, M., Memarzadeh, M. R., Asemi, Z., & Esmaillzadeh, A. (2016) · Nutrition · doi:10.1016/j.nut.2015.09.003 · Cited by 767 · cited 5×
“A study by Akkasheh [27] found that eight weeks of administration of probiotics to patients with major depressive disorder (MDD) had beneficial effects on Beck Depression Inventory scores.”
BackgroundMethodInfluential
Cited by
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
Vagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders
Breit, S., Kupferberg, A., Rogler, G., & Hasler, G. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00044 · Cited by 1,189
The microbiota-gut-brain axis: from motility to mood
Margolis, K. G., Cryan, J. F., & Mayer, E. A. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.10.066 · Cited by 999
The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders
Socała, K., Doboszewska, U., Szopa, A., Serefko, A., Włodarczyk, M., Zielińska, A., Poleszak, E., Fichna, J., & Wlaź, P. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105840 · Cited by 857
Malhi, G. S., Bell, E., Bassett, D., Boyce, P., Bryant, R., Hazell, P., Hopwood, M., Lyndon, B., Mulder, R., Porter, R., et al. (2021) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867420979353 · Cited by 614
“There is emerging support for the benefits of these supplements in the management of depressive disorders (Huang et al., 2016), but further research is necessary to confirm and clarify their clinical utility, effect sizes and optimal probiotic formulations (Goh et al., 2019).”
BackgroundLiu, R. T., Walsh, R. F. L., & Sheehan, A. E. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.03.023 · Cited by 564
“…of probiotics in this area (Huang et al., 2016; Liu et al., 2018; Ng et al., 2018; Pirbaglou et al., 2016; Reis et al., 2018; Wallace and Milev, 2017), including two meta-analyses of depression (Huang et al., 2016; Ng et al., 2018) and anxiety (Liu et al., 2018; Reis et al., 2018), respectively.”
BackgroundMethodResultInfluentialThe Microbiota–Gut–Brain Axis in Psychiatric Disorders
Góralczyk-Bińkowska, A., Szmajda-Krygier, D., & Kozłowska, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911245 · Cited by 495
Rudzki, L., Ostrowska, L., Pawlak, D., Małus, A., Pawlak, K., Waszkiewicz, N., & Szulc, A. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.10.010 · Cited by 499
“Taking this into account we see results of our study as the first steps in building up understanding of complex interactions between microbiota, kynurenines and CNS functions in the perspective of major depressive disorder and discussed above hypothetical models point to exciting directions for future studies.”
BackgroundInfluentialNutritional psychiatry: The present state of the evidence
Marx, W., Moseley, G., Berk, M., & Jacka, F. (2017) · Proceedings of the Nutrition Society · doi:10.1017/s0029665117002026 · Cited by 469
“Alternatively, a more recent meta-analysis of five RCT reported that probiotic supplementation decreased measures of depression (−0·30, 95 % CI −0·51, −0·09; P = 0·005)((100)), and an additional systematic review of ten RCT also concluded that probiotics may be beneficial to cognition, mood and anxiety((101)).”
The role of inflammation and the gut microbiome in depression and anxiety
Peirce, J. M., & Alviña, K. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24476 · Cited by 466
Probiotic supplements might not be universally-effective and safe: A review
Kothari, D., Patel, S., & Kim, S.-K. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.104 · Cited by 445
Microbiota-Gut-Brain Axis: New Therapeutic Opportunities
Long-Smith, C., O'Riordan, K. J., Clarke, G., Stanton, C., Dinan, T. G., & Cryan, J. F. (2020) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023628 · Cited by 419
Intestinal Lactobacillus in health and disease, a driver or just along for the ride?
Heeney, D. D., Gareau, M. G., & Marco, M. L. (2018) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.08.004 · Cited by 369
“Current Opinion in Biotechnology 2018, 49:140–147 and this is supported in probiotics studies which have indicated that probiotic Lactobacillus might improve symptoms of human depression [63,64].”
BackgroundA meta-analysis of the use of probiotics to alleviate depressive symptoms
Ng, Q. X., Peters, C., Ho, C. Y. X., Lim, D. Y., & Yeo, W.-S. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.11.063 · Cited by 357
Prescott, S. L., Larcombe, D.-L., Logan, A. C., West, C., Burks, W., Caraballo, L., Levin, M., Etten, E. V., Horwitz, P., Kozyrskyj, A., et al. (2017) · World Allergy Organization Journal · doi:10.1186/s40413-017-0160-5 · Cited by 347
“While the overall pool of studies remains small, meta-analyses of published intervention studies supports these original ideas; probiotics have been shown to improve emotional outlook and anxiety [163, 164].”
ResultThe effects of plant-based diets on the body and the brain: a systematic review
Medawar, E., Huhn, S., Villringer, A., & Veronica Witte, A. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0552-0 · Cited by 343
Probiotics and the microbiota-gut-brain axis: Focus on psychiatry
Mörkl, S., Butler, M. I., Holl, A., Cryan, J. F., & Dinan, T. G. (2020) · Current Nutrition Reports · doi:10.1007/s13668-020-00313-5 · Cited by 337
Heiss, C. N., & Olofsson, L. E. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12684 · Cited by 304
Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy
Shen, Y., Fan, N., Ma, S., Cheng, X., Yang, X., & Wang, G. (2025) · MedComm · doi:10.1002/mco2.70168 · Cited by 301
Psychobiotics in mental health, neurodegenerative and neurodevelopmental disorders
Cheng, L.-H., Liu, Y.-W., Wu, C.-C., Wang, S., & Tsai, Y.-C. (2019) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2019.01.002 · Cited by 291
Fatigue in IBD: epidemiology, pathophysiology and management
Borren, N. Z., van der Woude, C. J., & Ananthakrishnan, A. N. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0091-9 · Cited by 272
Revisit gut microbiota and its impact on human health and disease
Ding, R.-X., Goh, W.-R., Wu, R.-N., Yue, X.-Q., Luo, X., Khine, W. W. T., Wu, J.-R., & Lee, Y.-K. (2019) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2018.12.012 · Cited by 268
Effects of obesity on depression: A role for inflammation and the gut microbiota
Schachter, J., Martel, J., Lin, C.-S., Chang, C.-J., Wu, T.-R., Lu, C.-C., Ko, Y.-F., Lai, H.-C., Ojcius, D. M., & Young, J. D. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.08.026 · Cited by 253
“Notably, recent clinical studies indicate that probiotics also reduce depression symptoms in humans (Huang et al., 2016; Wallace and Milev, 2017).”
BackgroundThe influence of the gut microbiota on the bioavailability of oral drugs
Zhang, X., Han, Y., Huang, W., Jin, M., & Gao, Z. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.09.013 · Cited by 242
A review of probiotic supplementation in healthy adults: helpful or hype?
Khalesi, S., Bellissimo, N., Vandelanotte, C., Williams, S., Stanley, D., & Irwin, C. (2019) · European Journal of Clinical Nutrition · doi:10.1038/s41430-018-0135-9 · Cited by 242
Microbiome, inflammation, epigenetic alterations, and mental diseases
Alam, R., Abdolmaleky, H. M., & Zhou, J. (2017) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32567 · Cited by 240
The Microbiome in Psychology and Cognitive Neuroscience
Sarkar, A., Harty, S., Lehto, S. M., Moeller, A. H., Dinan, T. G., Dunbar, R. I. M., Cryan, J. F., & Burnet, P. W. J. (2018) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2018.04.006 · Cited by 232
Making Sense of … the Microbiome in Psychiatry
Bastiaanssen, T. F. S., Cowan, C. S. M., Claesson, M. J., Dinan, T. G., & Cryan, J. F. (2019) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy067 · Cited by 222
“These studies seem to hold translational value, with several systematic reviews indicating that probiotics effectively improve mood in humans (Huang et al., 2016; Pirbaglou et al., 2016; Wallace and Milev, 2017).”
ResultChen, Y.-H., Bai, J., Wu, D., Yu, S.-F., Qiang, X.-L., Bai, H., Wang, H.-N., & Peng, Z.-W. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.08.014 · Cited by 218
Gut microbiota in patients with Alzheimer’s disease spectrum: a systematic review and meta-analysis
Hung, C.-C., Chang, C.-C., Huang, C.-W., Nouchi, R., & Cheng, C.-H. (2022) · Aging · doi:10.18632/aging.203826 · Cited by 211
Antidepressive Mechanisms of Probiotics and Their Therapeutic Potential
Yong, S. J., Tong, T., Chew, J., & Lim, W. L. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01361 · Cited by 204
Alli, S. R., Gorbovskaya, I., Liu, J. C. W., Kolla, N. J., Brown, L., & Müller, D. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094494 · Cited by 202
Using probiotics in clinical practice: Where are we now? A review of existing meta-analyses
Rondanelli, M., Faliva, M. A., Perna, S., Giacosa, A., Peroni, G., & Castellazzi, A. M. (2017) · Gut Microbes · doi:10.1080/19490976.2017.1345414 · Cited by 199
Programming Bugs: Microbiota and the Developmental Origins of Brain Health and Disease
Codagnone, M. G., Spichak, S., O’Mahony, S. M., O’Leary, O. F., Clarke, G., Stanton, C., Dinan, T. G., & Cryan, J. F. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.06.014 · Cited by 198
Fan, Y., Zhu, T., Li, M., He, J., & Huang, R. (2017) · Journal of Healthcare Engineering · doi:10.1155/2017/4124302 · Cited by 190
Self-citationA psychology of the human brain-gut-microbiome axis
Allen, A. P., Dinan, T. G., Clarke, G., & Cryan, J. F. (2017) · Social and Personality Psychology Compass · doi:10.1111/spc3.12309 · Cited by 174
Ansari, F., Pourjafar, H., Tabrizi, A., & Homayouni, A. (2020) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201021666200107113812 · Cited by 170
Gutted! Unraveling the Role of the Microbiome in Major Depressive Disorder
Bastiaanssen, T. F. S., Cussotto, S., Claesson, M. J., Clarke, G., Dinan, T. G., & Cryan, J. F. (2020) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000243 · Cited by 159
PROVIT: Supplementary Probiotic Treatment and Vitamin B7 in Depression—A Randomized Controlled Trial
Reininghaus, E. Z., Platzer, M., Kohlhammer-Dohr, A., Hamm, C., Mörkl, S., Bengesser, S. A., Fellendorf, F. T., Lahousen-Luxenberger, T., Leitner-Afschar, B., Schöggl, H., et al. (2020) · Nutrients · doi:10.3390/nu12113422 · Cited by 157
Huang, R., Ning, H., Shen, M., Li, J., Zhang, J., & Chen, X. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00392 · Cited by 154
Self-citationPsychobiotics: The Next-Generation Probiotics for the Brain
Sharma, R., Gupta, D., Mehrotra, R., & Mago, P. (2021) · Current Microbiology · doi:10.1007/s00284-020-02289-5 · Cited by 181
Doroszkiewicz, J., Groblewska, M., & Mroczko, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810028 · Cited by 148
Evolution of the Human Diet and Its Impact on Gut Microbiota, Immune Responses, and Brain Health
Olmo, B. M. G., Butler, M. J., & Barrientos, R. M. (2021) · Nutrients · doi:10.3390/nu13010196 · Cited by 179
Skonieczna-Żydecka, K., Marlicz, W., Misera, A., Koulaouzidis, A., & Łoniewski, I. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7120521 · Cited by 147
“In addition, meta-analyses have shown that probiotic intervention may positively affect the mood in healthy persons as well as depressive patients [159].”
BackgroundGut Microbiota: A Perspective for Psychiatrists
Rea, K., Dinan, T. G., & Cryan, J. F. (2020) · Neuropsychobiology · doi:10.1159/000504495 · Cited by 141
Park, M., Choi, J., & Lee, H.-J. (2020) · Nutrients · doi:10.3390/nu12061815 · Cited by 139
Dickerson, F., Adamos, M., Katsafanas, E., Khushalani, S., Origoni, A., Savage, C., Schweinfurth, L., Stallings, C., Sweeney, K., Goga, J., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12652 · Cited by 137
Yang, Z., Li, J., Gui, X., Shi, X., Bao, Z., Han, H., & Li, M. D. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0729-1 · Cited by 152
“Those investigators also found that probiotics were more effective for the population under age 60 years than for older subjects [101].”
BackgroundSun, L., Ma, L., Zhang, H., Cao, Y., Wang, C., Hou, N., Huang, N., von Deneen, K. M., Zhao, C., Shi, Y., et al. (2019) · Theranostics · doi:10.7150/thno.31562 · Cited by 136
Gut microbiota in various childhood disorders: Implication and indications
Saeed, N. K., Al‐Beltagi, M., Bediwy, A. S., El-Sawaf, Y., & Toema, O. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i18.1875 · Cited by 173
Tian, P., Zou, R., Wang, L., Chen, Y., Qian, X., Zhao, J., Zhang, H., Qian, L., Wang, Q., Wang, G., et al. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2022.05.003 · Cited by 145
“The effects of probiotics on MDD-comorbid gastrointestinal dysfunction has rarely been investigated [36,37].”
BackgroundOrtega, M. A., Álvarez-Mon, M. Á., Montero, C. G., Fraile‐Μartinez, O., Monserrat, J., Martinez-Rozas, L., Rodríguez–Jiménez, R., Álvarez‐Mon, M., & Lahera, G. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-01964-w · Cited by 150
Chao, L., Liu, C., Sutthawongwadee, S., Li, Y., Lv, W., Chen, W., Yu, L., Zhou, J., Guo, A., Li, Z., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00421 · Cited by 125
Probiotics, Nutrition, and the Small Intestine
Judkins, T. C., Archer, D. L., Kramer, D. C., & Solch-Ottaiano, R. J. (2020) · Current Gastroenterology Reports · doi:10.1007/s11894-019-0740-3 · Cited by 147
The Therapeutic Potential of Plant Polysaccharides in Metabolic Diseases
Wang, X., Chen, X., Tang, Y., Wu, J., Qin, D., Yu, L., Yu, C., Zhou, X., & Wu, A. (2022) · Pharmaceuticals · doi:10.3390/ph15111329 · Cited by 138
Virk, M. S., Virk, M. A., He, Y., Tufail, T., Gul, M., Qayum, A., Rehman, A., Rashid, A., Ekumah, J., Han, X., et al. (2024) · Nutrients · doi:10.3390/nu16040546 · Cited by 158
Complementary therapies for clinical depression: an overview of systematic reviews
Haller, H., Anheyer, D., Cramer, H., & Dobos, G. J. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-028527 · Cited by 151
Probiotics for the treatment of depressive symptoms: An anti-inflammatory mechanism?
Park, C., Brietzke, E., Rosenblat, J. D., Musial, N., Zuckerman, H., Ragguett, R.-M., Pan, Z., Rong, C., Fus, D., & McIntyre, R. S. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.07.006 · Cited by 123
Rudzki, L., Stone, T. W., Maes, M. H. J., Misiak, B., Samochowiec, J., & Szulc, A. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110240 · Cited by 153
Fecal transplant prevents gut dysbiosis and anxiety-like behaviour after spinal cord injury in rats
Schmidt, E. K. A., Torres-Espin, A., Raposo, P. J. F., Madsen, K. L., Kigerl, K. A., Popovich, P. G., Fenrich, K. K., & Fouad, K. (2020) · PLoS ONE · doi:10.1371/journal.pone.0226128 · Cited by 119
“Since then, many studies have strengthened the connection between microbiota changes and behaviour in animal modles [10,47,48] and humans [49,50].”
BackgroundEmerging Evidence for the Widespread Role of Glutamatergic Dysfunction in Neuropsychiatric Diseases
McGrath, T., Baskerville, R., Rogero, M. M., & Castell, L. M. (2022) · Nutrients · doi:10.3390/nu14050917 · Cited by 134
The Therapeutic Role of Ketogenic Diet in Neurological Disorders
Pietrzak, D., Kasperek, K., Rękawek, P., & Piątkowska-Chmiel, I. (2022) · Nutrients · doi:10.3390/nu14091952 · Cited by 115
Roman, P., Estévez, A. F., Miras, A., Sánchez-Labraca, N., Cañadas, F., Vivas, A. B., & Cardona, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-29388-5 · Cited by 116
The Microbiota-Gut-Immune-Glia (MGIG) Axis in Major Depression
Rudzki, L., & Maes, M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01961-y · Cited by 111
“Furthermore, growing clinical data confirms the therapeutic effects of so-called psychobiotics in those disorders (32, 48-64).”
BackgroundGut-Brain Axis: Role of Microbiome, Metabolomics, Hormones, and Stress in Mental Health Disorders
Verma, A., Inslicht, S. S., & Bhargava, A. (2024) · Cells · doi:10.3390/cells13171436 · Cited by 160
“Pharmacotherapy options involve antidepressant drugs such as selective serotonin reuptake inhibitors, serotonin–norepinephrine reuptake inhibitors, atypical antidepressants, tricyclic antidepressants, serotonin antagonist and reuptake inhibitors, or lithium [155].”
BackgroundAmirani, E., Milajerdi, A., Mirzaei, H., Jamilian, H., Mansournia, M. A., Hallajzadeh, J., & Ghaderi, A. (2020) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2020.102361 · Cited by 113
Medina-Rodriguez, E. M., Madorma, D., O’Connor, G., Mason, B. L., Han, D., Deo, S. K., Oppenheimer, M., Nemeroff, C. B., Trivedi, M. H., Daunert, S., et al. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.19090960 · Cited by 110
“Two samples (1 HC and 1 MDD, who had a primary Bipolar diagnosis) were not used for IL-17A and SAA measures because of the nature of the stools (diarrhea), for which 50 mg of actual stool could not be sampled to get protein concentrations consistent with the other samples.”
InfluentialJee, H. J., Lee, S. G., Bormate, K. J., & Jung, Y.-S. (2020) · Nutrients · doi:10.3390/nu12103080 · Cited by 111
Eating Disorders and Gastrointestinal Diseases
Santonicola, A., Gagliardi, M., Guarino, M. P. L., Siniscalchi, M., Ciacci, C., & Iovino, P. (2019) · Nutrients · doi:10.3390/nu11123038 · Cited by 107
Depression and Obesity: Analysis of Common Biomarkers
Milano, W., Ambrosio, P., Carizzone, F., De Biasio, V., Di Munzio, W., Foia, M. G., & Capasso, A. (2020) · Diseases · doi:10.3390/diseases8020023 · Cited by 106
Zhang, C., Zhang, Y., Li, H., & Liu, X. (2020) · Food & Function · doi:10.1039/c9fo02961c · Cited by 121
Pathways linking obesity to neuropsychiatric disorders
Martins, L. B., Monteze, N. M., Calarge, C. A., Ferreira, A. V. M., & Teixeira, A. L. (2019) · Nutrition · doi:10.1016/j.nut.2019.03.017 · Cited by 120
Potential roles of gut microbiota and microbial metabolites in Parkinson’s disease
Zheng, S.-Y., Li, H.-X., Xu, R.-C., Miao, W.-T., Dai, M.-Y., Ding, S.-T., & Liu, H.-D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101347 · Cited by 101
Microbiota-gut-brain research: A critical analysis
Hooks, K. B., Konsman, J. P., & O'Malley, M. A. (2019) · Behavioral and Brain Sciences · doi:10.1017/s0140525x18002133 · Cited by 98
Wang, P., Zhang, Y., Gong, Y., Yang, R., Chen, Z., Hu, W., Wu, Y., Gao, M., Xu, X., Qin, Y., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.12.006 · Cited by 97
Gut microbiota variations in patients diagnosed with major depressive disorder—A systematic review
Knudsen, J. K., Bundgaard‐Nielsen, C., Hjerrild, S., Nielsen, R. E., Leutscher, P., & Sørensen, S. (2021) · Brain and Behavior · doi:10.1002/brb3.2177 · Cited by 97
“This is supported by clinical studies where supplementation with probiotics, which produce SCFAs, reduced depressive symptoms in patients with MDD (Huang et al., 2016), presumably caused by limiting low- grade inflammation (Jakobsen et al., 2017; Park et al., 2018; Yu et al., 2017).”
ResultBorrego-Ruiz, A., & Borrego, J. J. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110861 · Cited by 120
“These fungi maintain the ecological and immune gut microbiome equilibrium (Huffnagle and Noverr, 2013).”
The connection between microbiome and schizophrenia
Golofast, B., & Vales, K. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.12.011 · Cited by 92
Karakula-Juchnowicz, H., Rog, J., Juchnowicz, D., Łoniewski, I., Skonieczna-Żydecka, K., Krukow, P., Futyma-Jedrzejewska, M., & Kaczmarczyk, M. (2019) · Nutrition Journal · doi:10.1186/s12937-019-0475-x · Cited by 93
Vaghef-Mehrabany, E., Maleki, V., Behrooz, M., Ranjbar, F., & Ebrahimi-Mameghani, M. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2019.06.004 · Cited by 89
Zhu, X., Hu, J., Deng, S., Tan, Y., Qiu, C., Zhang, M., Ni, X., Lu, H., Wang, Z., Li, L., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.587670 · Cited by 101
“Many human studies have also shown that probiotics are associated with a significant reduction in depression (18), possibly through an anti-inflammatory mechanism (19).”
BackgroundSelf-citationGut microbiota‐immune‐brain interactions in chemotherapy‐associated behavioral comorbidities
Jordan, K. R., Loman, B. R., Bailey, M. T., & Pyter, L. M. (2018) · Cancer · doi:10.1002/cncr.31584 · Cited by 86
“Alterations in microbial communities also are associated with affective disorders in humans.47-49 For example, fecal bacterial communities from patients with major depressive disorder (MDD) are distinct from those in healthy individuals, and patients with MDD have an increased relative abundance of Actinobacteria and…”
Immune-based strategies for mood disorders: facts and challenges
Colpo, G. D., Leboyer, M., Dantzer, R., Trivedi, M. H., & Teixeira, A. L. (2018) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2018.1407242 · Cited by 89
“Five clinical trials comprising 183 cases and 182 controls showed that probiotics significantly decreased depressive symptoms in patients with MDD and healthy subjects [152].”
BackgroundMerkouris, E., Mavroudi, T., Miliotas, D., Tsiptsios, D., Serdari, A., Christidi, F., Doskas, T. K., Mueller, C., & Tsamakis, K. (2024) · Microorganisms · doi:10.3390/microorganisms12020411 · Cited by 110
“When looking at meta-analytic data, two relatively older studies from 2016 and 2017 examining the effectiveness of probiotics in alleviating depression revealed a general improvement of depressive symptoms following probiotic ingestion, with minimal potential for negative side effects [32,33].”
ResultInfluentialAlcohol, microbiome, and their effect on psychiatric disorders
Hillemacher, T., Bachmann, O., Kahl, K. G., & Frieling, H. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.04.015 · Cited by 87
“A variety of pathologies are associated with changes in the community structure and function of the gut microbiota, suggesting a link between dysbiosis and disease etiology, including irritable bowel syndrome,(Butto and Haller, 2016) depression,(Huang et al., 2016; Lurie et al., 2015; Macedo et al., 2017; Slyepchenko…”
Butler, M., Mörkl, S., Sandhu, K. V., Cryan, J. F., & Dinan, T. G. (2019) · The Canadian Journal of Psychiatry · doi:10.1177/0706743719874168 · Cited by 117
“In addition, the antidepressant effects of probiotics seem to be limited to younger adults and not evident in those over the age of 65 years.(74) Another area of concern is the major interstudy discrepancies in relation to probiotic dosing and duration of treatment, which has reduced the comparability of current clini…”
BackgroundGut microbiota, kynurenine pathway and mental disorders – Review
Więdłocha, M., Marcinowicz, P., Janoska-Jaździk, M., & Szulc, A. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110145 · Cited by 99
Dionysopoulou, S., Charmandari, E., Bargiota, Α., Vlahos, N., Mastorakos, G. P., & Valsamakis, G. (2021) · Nutrients · doi:10.3390/nu13020498 · Cited by 101
Žučko, J., Starčević, A., Diminić, J., Oros, D., Mortazavian, A. M., & Putnik, P. (2020) · Current Opinion in Food Science · doi:10.1016/j.cofs.2020.01.007 · Cited by 98
Lam, Y., Maguire, S., Palacios, T., & Caterson, I. (2017) · Nutrients · doi:10.3390/nu9060602 · Cited by 86
Dong, T. S., & Mayer, E. A. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.01.024 · Cited by 92
“84,85 In mice, Bi fi dobacterium breve reversed chronic stress-induced depression-like behavior.”
BackgroundAlterations in the gut microbiota of patients with silica-induced pulmonary fibrosis
Zhou, Y., Lv, C., Sun, G., Li, Y., & Huang, R. (2019) · Journal of Occupational Medicine and Toxicology · doi:10.1186/s12995-019-0225-1 · Cited by 87
Self-citationThe Development of High-Quality Multispecies Probiotic Formulations: From Bench to Market
Grumet, L., Tromp, Y., & Stiegelbauer, V. (2020) · Nutrients · doi:10.3390/nu12082453 · Cited by 107
Gut Microbiota and Bipolar Disorder: An Overview on a Novel Biomarker for Diagnosis and Treatment
Lucidi, L., Pettorruso, M., Vellante, F., Carlo, F. D., Ceci, F., Santovito, M. C., Muzio, I. D., Fornaro, M., Ventriglio, A., Tomasetti, C., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073723 · Cited by 88
Efficacy of probiotics on anxiety-A meta-analysis of randomized controlled trials
Liu, B., He, Y., Wang, M., Liu, J., Ju, Y., Zhang, Y., Liu, T., Li, L., & Li, Q. (2018) · Depression and Anxiety · doi:10.1002/da.22811 · Cited by 81
Tremblay, A., Lingrand, L., Maillard, M., Feuz, B., & Tompkins, T. A. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110142 · Cited by 95
Rudzki, L., & Szulc, A. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00205 · Cited by 80
Gut-brain axis: A matter of concern in neuropsychiatric disorders…!
Naveed, M., Zhou, Q.-G., Chu, X., Taleb, A., Meng, F. J., Ahmed, B., Zhang, Y., Fukunaga, K., & Han, F. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110051 · Cited by 102
Sun, C., Li, J., Wang, Y., Lin, S., Ou, Y., Lin, C., Wang, J., Liao, S., & Chen, C. (2021) · Aging · doi:10.18632/aging.202523 · Cited by 85
El Dib, R., Periyasamy, A. G., de Barros, J. L., França, C. G., Senefonte, F. L., Vesentini, G., Alves, M. G. O., Rodrigues, J. V. D. S., Gomaa, H., Gomes Júnior, J. R., et al. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.07.027 · Cited by 75
Metadata
- Authors
- Huang, R., Wang, K., & Hu, J.
- Affiliations
- Central South University (CN)
- Corresponding author
- Hu, Jianan
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2016-08-06
- Volume
- 8
- Issue
- 8
- Pages
- 483
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC4997396
- OpenAlex
- W2478760258
- Cited by
- 505
- References
- 42
- Citations by year
- 2026: 26 · 2025: 43 · 2024: 63 · 2023: 71 · 2022: 63 · 2021: 64 · 2020: 59 · 2019: 46 · 2018: 44 · 2017: 24 · 2016: 1
- FWCI
- 4.43
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (81372966)
- Central South University
- Open-End Fund for the Valuable and Precision Instruments of Central South University
- Division of Graduate Education
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- probiotics, depression, major depressive disorder, gut-brain axis, depressive symptoms, depression prevention
- MeSH terms
- Adult, Age Factors, Animals, Depression, Depressive Disorder, Major, Major Depressive Disorder, Humans, Risk, Global Health, Randomized Controlled Trials as Topic, Evidence-Based Medicine, Probiotics, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.